A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

It is made from human blood plasma and is, therefore, known as a biologic drug product ... Treating MS With Intravenous ...

a biologic therapy shown effective at controlling the symptoms of RA in patients who fail to respond to traditional disease-modifying antirheumatic drugs (DMARDs). To assess the risk of cancer ...

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic ...

looked at the intratumoral expression of various biologic markers that may be useful for the treatment of resectable non-small-cell lung cancers (NSCLCs). The authors carried out ...

This trial, known as INVISE, marks a groundbreaking moment in cancer treatment as it explores ... The innovative approach of ...